Top Priority Sector: disaster_preparedness_emergency_response Inovio Pharmaceuticals, Inc. expanded its existing license agreement on Nov. 14 with the University of Pennsylvania (UPenn), adding worldwide rights to technology and intellectual property for novel synthetic vaccines against potential biodefense pathogens, cancer, and infectious diseases. The technologies were developed by UPenn Professor David Weiner…
Ten million H1NI flu vaccines produced in one month, says DARPA
Mark Rockwell Top Priority Sector: cbrne_detection Image Caption: DARPA’s vaccine source A DARPA-funded vaccine company working on ways to quickly develop immunizations for potential pandemics, has successfully made over 10 million doses of H1N1 flu vaccine in a single month. Homepage position: 10 read more View full post on Government…
Morning Security Brief: No Credible NATO Threats, Testing Emergency Vaccines on Children, U.S. Not Safe from Stuxnet, and More
read more View full post on Security Management News & Analysis View full post on National Cyber Security
